Arcutis Biotherapeutics Inc (ARQT)
SG&A Expense Growth
10.88%
Quarterly · Period ending:
ARQT SG&A Expense Growth
Latest reported10.88%period ending
Latest reported10.88%period ending
ARQT Quarterly SG&A Growth (QoQ) (0.00% → 10.88%)
Latest values, visible window
High-resolution chart · PNG
ARQT sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 10.8834% | |
| -6.2056% | |
| 26.5576% | |
| -9.7817% | |
| 8.0747% | |
| 11.1011% | |
| -2.0572% | |
| 1.107% | |
| 6.1667% | |
| 12.5734% | |
| 2.267% | |
| 3.5619% | |
| 7.0833% | |
| 15.9225% | |
| 4.3695% | |
| 28.423% | |
| 25.5203% | |
| 17.5032% | |
| 13.6822% | |
| 45.5943% | |
| -21.7172% | |
| 116.0538% | |
| 20.3237% | |
| -1.0324% | |
| 61.9487% | |
| 55.0738% | |
| -2.7391% | |
| 73.716% | |
| 76.769% | |
| 23.5974% | |
| -1.3029% | |
| 113.5652% | |
| 0% | |
| 0% |